Jinling Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinling Pharmaceutical Company Limited with three other
companies in this sector in China:
Renhe Pharmacy Company Limited
sales of 3.57 billion Chinese Renmimbi [US$553.51 million]
of which 99%
Guizhou Yibai Pharmaceutical Co., Ltd.
(3.69 billion Chinese Renmimbi [US$572.12 million]
of which 86%
was Medical Industry), and
JiangSu Bicon Pharmaceutical Listed Co
(3.72 billion Chinese Renmimbi [US$577.86 million]
of which 65%
was Pharmaceutical Intermediates).
Jinling Pharmaceutical Company Limited reported sales of 3.58 billion Chinese Renmimbi (US$555.14 million)
December of 2016.
increase of 11.1%
versus 2015, when the company's sales were 3.22 billion Chinese Renmimbi.
Sales at Jinling Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 59%).
Sales of Medical Service saw an increase
19.0% in 2016, from
699.95 million Chinese Renmimbi to 832.96 million Chinese Renmimbi.